Workflow
Wave Life Sciences .(WVE)
icon
Search documents
Wave Life Sciences .(WVE) - 2021 Q1 - Earnings Call Transcript
2021-05-13 17:19
Wave Life Sciences Ltd. (NASDAQ:WVE) Q1 2021 Earnings Conference Call May 13, 2021 8:30 AM ET Company Participants Kate Rausch - Head of Investor Relations Paul Bolno - President & Chief Executive Officer Mike Panzara - Chief Medical Officer, Head of Therapeutics Discovery & Development Kyle Moran - Chief Financial Officer Conference Call Participants Michael Lin - Mizuho Joon Lee - Truist Mani Foroohar - SVB Leerink Eun Yang - Jefferies Operator Good morning and welcome to the Wave Life Sciences First Quar ...
Wave Life Sciences .(WVE) - 2021 Q1 - Earnings Call Presentation
2021-05-13 16:47
Wave Life Sciences First Quarter 2021 Earnings May 13, 2021 Forward-looking statements 2 This document contains forward-looking statements. All statements other than statements of historical facts contained in this document, including statements regarding possible or assumed future results of operations, preclinical and clinical studies, business strategies, research and development plans, collaborations and partnerships, regulatory activities and timing thereof, competitive position, potential growth oppor ...
Wave Life Sciences .(WVE) - 2020 Q4 - Earnings Call Presentation
2021-03-05 17:35
Wave Life Sciences Fourth Quarter and Full Year 2020 Earnings March 4, 2021 Forward-looking statements 2 This document contains forward-looking statements. All statements other than statements of historical facts contained in this document, including statements regarding possible or assumed future results of operations, preclinical and clinical studies, business strategies, research and development plans, collaborations and partnerships, regulatory activities and timing thereof, competitive position, potent ...
Wave Life Sciences .(WVE) - 2020 Q4 - Earnings Call Transcript
2021-03-04 19:12
Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2020 Results Earnings Conference Call March 4, 2021 8:00 AM ET Company Participants Kate Rausch - Head of Investor Relations Paul Bolno - President and Chief Executive Officer Michael Panzara - Chief Medical Officer, Head of Therapeutics Discovery and Development Kyle Moran - Chief Financial Officer Conference Call Participants Salim Syed - Mizuho Securities Joon Lee - Truist Securities Mani Foroohar - SVB Leerink Thor Nagel - Stifel Financial Corp. Lisa Walter - RBC ...
Wave Life Sciences .(WVE) - 2020 Q3 - Earnings Call Presentation
2020-11-10 14:54
Wave Life Sciences Third Quarter 2020 Earnings November 9, 2020 Forward-looking statements 2 This document contains forward-looking statements. All statements other than statements of historical facts contained in this document, including statements regarding possible or assumed future results of operations, preclinical and clinical studies, business strategies, research and development plans, collaborations and partnerships, regulatory activities and timing thereof, competitive position, potential growth o ...
Wave Life Sciences .(WVE) - 2020 Q3 - Earnings Call Transcript
2020-11-09 17:33
Wave Life Sciences Ltd. (NASDAQ:WVE) Q3 2020 Earnings Conference Call November 9, 2020 8:30 AM ET Company Participants Graham Morrell - IR Paul Bolno - President and CEO Mike Panzara - Chief Medical Officer, Head of Therapeutics Discovery and Development Dave Gaiero - Interim CFO Chandra Vargeese - Chief Technology Officer Ken Rhodes - SVP, Therapeutics Discovery Conference Call Participants Joon Lee - Truist Securities Rick Bienkowski - SVB Leerink Salim Syed - Mizuho Securities Eun Yang - Jefferies Jeffer ...
Wave Life Sciences (WVE) Presents at H.C. Wainwright Annual Global Investment Conference - Slideshow
2020-09-18 17:50
| --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | 1 Forward-looking statements 2 This document contains forward-looking statements. All statements other than statements of historical facts contained in this document, including statements regarding possible or assumed future results of operations, preclinical and clinical studies, business strategies, research and development plans, collaborations and partnerships, regulatory activities and ti ...